Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion

Código QR

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion

Retinal vein occlusion is one of the most severe vascular lesions of the organ of vision, usually accompanied by somatic pathology.The aim of the study was to study the somatic status and individual biochemical markers in patients with retinal vein occlusion and comparison in groups opposing the eff...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	I. V. Zlobin, T. N. Iureva, Yu. V. Kursakova
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2019
Materias:	retinal vein occlusion somatic status arterial hypertension anti-vegf therapy ranibizumab Science Q
Acceso en línea:	https://doaj.org/article/79b9cb03548d443cb6337480c3eed96f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
por: Jumper JM, et al.
Publicado: (2018)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
por: Callizo J, et al.
Publicado: (2019)

Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes
por: Dixon SG, et al.
Publicado: (2016)

Central retinal vein occlusion and pseudoexfoliation syndrome
por: Karagiannis D, et al.
Publicado: (2015)

Dexamethasone implant in retinal vein occlusions
por: Han SB, et al.
Publicado: (2016)

TRANSPUPILLARY THERMOTHERAPY OF THE OPTIC NERVE DISK IN THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION
por: M. V. Akulenko, et al.
Publicado: (2016)

Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion
por: Peng-Yao Lin, et al.
Publicado: (2021)

Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
por: Kawamura M, et al.
Publicado: (2018)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
por: Sakanishi Y, et al.
Publicado: (2017)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
por: Tagami M, et al.
Publicado: (2017)

Retinal vein occlusion with cerebral infarction in a preterm neonate: a case report
por: Xiuyu Zhu, et al.
Publicado: (2021)

Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
por: Narayanan R, et al.
Publicado: (2016)

Systemic abnormalities associated with retinal vein occlusion in young patients
por: Sinawat S, et al.
Publicado: (2017)

Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
por: Kim M
Publicado: (2016)

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
por: Dogan E, et al.
Publicado: (2018)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine I, et al.
Publicado: (2017)

Hyperreflectivity of Inner Retinal Layers as a Quantitative Parameter of Ischemic Damage in Acute Retinal Vein Occlusion (RVO): An Optical Coherence Tomography Study
por: Furashova O, et al.
Publicado: (2020)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
por: Sivaprasad S, et al.
Publicado: (2016)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose R, et al.
Publicado: (2016)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska B, et al.
Publicado: (2017)

Vitrectomy for macular edema due to retinal vein occlusion
por: Kumagai K, et al.
Publicado: (2019)

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
por: Wallsh J, et al.
Publicado: (2016)

Artificial intelligence can assist with diagnosing retinal vein occlusion
por: Qiong Chen, et al.
Publicado: (2021)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
por: Singer MA, et al.
Publicado: (2016)

Anti-VEGF treatment and peripheral retinal nonperfusion in patients with central retinal vein occlusion
por: Abri Aghdam K, et al.
Publicado: (2017)

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
por: Oellers P, et al.
Publicado: (2016)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
por: Wallsh J, et al.
Publicado: (2020)

Relationship between vascular endothelial growth factor and macular edema in retinal vein branch obstruction
por: Okawada H, et al.
Publicado: (2018)

Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
por: Sakanishi Y, et al.
Publicado: (2016)

Efficacy of anti-VEGF therapy combined with iontophoresis of Xueshuantong injection on retinal vein obstruction with macular edema
por: Zi-Yue Xiang, et al.
Publicado: (2021)

Morphologic Classifications and Locations of Microaneurysms and Clinical Relevance in Branch Retinal Vein Occlusion
por: Esaki Y, et al.
Publicado: (2020)

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
por: Michalska-Małecka K, et al.
Publicado: (2016)

STUDIES OF SYSTEMIC AND LOCAL CYTOKINE LEVEL IN RETINAL VEIN OCCLUSION ASSOCIATED WITH ANTIANGIOGENIC THERAPY
por: E. A. Drozdova, et al.
Publicado: (2018)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
por: Takeyama M, et al.
Publicado: (2017)

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail A, et al.
Publicado: (2018)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
por: Kumagai K, et al.
Publicado: (2019)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
por: Tsai MJ, et al.
Publicado: (2018)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
por: Kim MS, et al.
Publicado: (2021)

Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion
por: Nishida A, et al.
Publicado: (2017)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
por: Andrzej Grzybowski, et al.
Publicado: (2021)